PLK1 and osteosarcoma: The gene expression results confirmed that siPLK1 delivered by ALC-PEI significantly reduced the PLK1 mRNA expression in Kirsten human osteogenic sarcoma (KHOS) cells in comparison with the scramble control and free siPLK1 (Figure 2g).